Figure 5
Figure 5. Hierarchical relationships of FLT3-ITD and D835 clones. (A) In all 6 cases, the predominant FLT3-ITD clones in blastsnaive and blastsresist were detectable in the LIC (the engrafted population). (B) Quantitative analysis of FLT3-ITD allelic burden in the engrafted LIC clone showed heterozygosity in 4 samples and homozygosity in 2 samples. (C) Allele specific enzyme digestion for D835 mutation was performed in both transplanted and engrafted blastsnaive and blastsresist. D835Y mutation was observed in the LIC population but not in the input blastsnaive in AML1, AML4, and AML10. The D835H mutation was not detectable in either transplanted or engrafted blastsnaive, in AML3 and AML7. In AML8, it was detectable in the input and engrafted blastsresist. In the blastsnaive, it was only 3% (Table 1). (D) When mice engrafted with blastsnaive from AML8 were treated with sorafenib, D835H mutation emerged. (E) Quantitative analysis of FLT3-D835 allelic burden confirmed the enrichment of the D835Y clone in the LIC population of blastsnaive in patients AML1, AML4, and AML10. No significant difference before and after transplantation was observed for blastsresist.

Hierarchical relationships of FLT3-ITD and D835 clones. (A) In all 6 cases, the predominant FLT3-ITD clones in blastsnaive and blastsresist were detectable in the LIC (the engrafted population). (B) Quantitative analysis of FLT3-ITD allelic burden in the engrafted LIC clone showed heterozygosity in 4 samples and homozygosity in 2 samples. (C) Allele specific enzyme digestion for D835 mutation was performed in both transplanted and engrafted blastsnaive and blastsresist. D835Y mutation was observed in the LIC population but not in the input blastsnaive in AML1, AML4, and AML10. The D835H mutation was not detectable in either transplanted or engrafted blastsnaive, in AML3 and AML7. In AML8, it was detectable in the input and engrafted blastsresist. In the blastsnaive, it was only 3% (Table 1). (D) When mice engrafted with blastsnaive from AML8 were treated with sorafenib, D835H mutation emerged. (E) Quantitative analysis of FLT3-D835 allelic burden confirmed the enrichment of the D835Y clone in the LIC population of blastsnaive in patients AML1, AML4, and AML10. No significant difference before and after transplantation was observed for blastsresist.

Close Modal

or Create an Account

Close Modal
Close Modal